Preventing the cell’s protein factories from making the notorious cancer-causing protein MYC could stop out-of-control tumors.
Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP
SAN DIEGO — Treatment with eltrombopag (Promacta) for pediatric patients with newly diagnosed immune thrombocytopenia (ITP) led to a significantly higher rate of durable platelet